Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Burrell

Showing results (31-40 of 88) with videos related to

Pageof 9
Sort By:
Journal of Hypertension|June 1, 1997
Elevated vascular angiotensin converting enzyme mediates increased neointima formation after balloon injury in spontaneously hypertensive ratsK Jandeleit-Dahm, L M Burrell, C I Johnston, et al.
The Medical Journal of Australia|January 2, 1995
Congestive cardiac failure and arrhythmiasP A Phillips, L M Burrell, A M Tonkin, et al.
American Journal of Physiology. Renal Physiology|June 18, 2010
Angiotensin II mediates epithelial-to-mesenchymal transformation in tubular cells by ANG 1-7/MAS-1-dependent pathwaysW C Burns, E Velkoska, R Dean, et al.
Journal of Immunoassay|January 1, 1990
A new radioimmunoassay for human alpha atrial natriuretic peptide and its physiological validationL M Burrell, J Palmer, J A Charlton, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 1, 1997
Chronic vasopressin antagonism in two-kidney, one-clip renovascular hypertensionL M Burrell, J Risvanis, P A Phillips, et al.
American Journal of Hematology|May 1, 1994
Pure red cell aplasia after chemotherapy for Hodgkin's lymphoma: in vitro evidence for T cell mediated suppression of erythropoiesis and response to sequential cyclosporin and erythropoietinT J Reid, M Mullaney, L M Burrell, et al.
Experimental Physiology|May 5, 2000
Vasopressin receptor antagonism--a therapeutic option in heart failure and hypertensionL M Burrell, J Risvanis, C I Johnston, et al.
Journal of Hypertension|June 8, 2001
In-vitro and in-vivo inhibition of rat neutral endopeptidase and angiotensin converting enzyme with the vasopeptidase inhibitor gemopatrilatR A Hubner, E Kubota, D J Casley, et al.
Clinical Science (London, England : 1979)|July 1, 1997
Inhibition of neutral endopeptidase, the degradative enzyme for natriuretic peptides, in rat kidney after oral SCH 42495L M Burrell, N Farina, J Risvanis, et al.
Kidney International|February 1, 1991
Osmoregulation of thirst and vasopressin release in severe chronic renal failureN B Argent, L M Burrell, T H Goodship, et al.
Pageof 9

Showing results (31-40 of 88) with videos related to

Sort By:
Pageof 9
Journal of Hypertension|June 1, 1997
Elevated vascular angiotensin converting enzyme mediates increased neointima formation after balloon injury in spontaneously hypertensive ratsK Jandeleit-Dahm, L M Burrell, C I Johnston, et al.
The Medical Journal of Australia|January 2, 1995
Congestive cardiac failure and arrhythmiasP A Phillips, L M Burrell, A M Tonkin, et al.
American Journal of Physiology. Renal Physiology|June 18, 2010
Angiotensin II mediates epithelial-to-mesenchymal transformation in tubular cells by ANG 1-7/MAS-1-dependent pathwaysW C Burns, E Velkoska, R Dean, et al.
Journal of Immunoassay|January 1, 1990
A new radioimmunoassay for human alpha atrial natriuretic peptide and its physiological validationL M Burrell, J Palmer, J A Charlton, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 1, 1997
Chronic vasopressin antagonism in two-kidney, one-clip renovascular hypertensionL M Burrell, J Risvanis, P A Phillips, et al.
American Journal of Hematology|May 1, 1994
Pure red cell aplasia after chemotherapy for Hodgkin's lymphoma: in vitro evidence for T cell mediated suppression of erythropoiesis and response to sequential cyclosporin and erythropoietinT J Reid, M Mullaney, L M Burrell, et al.
Experimental Physiology|May 5, 2000
Vasopressin receptor antagonism--a therapeutic option in heart failure and hypertensionL M Burrell, J Risvanis, C I Johnston, et al.
Journal of Hypertension|June 8, 2001
In-vitro and in-vivo inhibition of rat neutral endopeptidase and angiotensin converting enzyme with the vasopeptidase inhibitor gemopatrilatR A Hubner, E Kubota, D J Casley, et al.
Clinical Science (London, England : 1979)|July 1, 1997
Inhibition of neutral endopeptidase, the degradative enzyme for natriuretic peptides, in rat kidney after oral SCH 42495L M Burrell, N Farina, J Risvanis, et al.
Kidney International|February 1, 1991
Osmoregulation of thirst and vasopressin release in severe chronic renal failureN B Argent, L M Burrell, T H Goodship, et al.
Pageof 9